CEACAM5 and non-small cell lung carcinoma: However, these serum protein biomarkers of NSCLC currently used in clinical practice, such as cytokeratin 19 fragment (Cyfra21-1), carcinoembryonic antigen (CEA) and SCC antigen, often exhibited lower diagnostic sensitivity and specificity 6.